European Best Practice Guidelines 5 -: Target haemoglobin

被引：19

作者：

Jacobs, C

Hörl, WH

Macdougall, IC

Valderrábano, F

Parrondo, I

Segner, A

Abraham, IL

机构：

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2000年 / 15卷

关键词：

D O I：

10.1093/ndt/15.suppl_4.15

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

引用

页码：15 / 19

页数：5

共 21 条

[1] A preliminary study of the effects of correction of anemia with recombinant human erythropoietin therapy on sleep, sleep disorders, and daytime sleepiness in hemodialysis patients (The SLEEPO study) [J].

Benz, RL ;

Pressman, MR ;

Hovick, ET ;

Peterson, DD .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (06) :1089-1095

[2] Effects of normal hematocrit on ambulatory blood pressure in epoetin-treated hemodialysis patients with cardiac disease [J].

Berns, JS ;

Rudnick, MR ;

Cohen, RM ;

Bower, JD ;

Wood, BC .

KIDNEY INTERNATIONAL, 1999, 56 (01) :253-260

[3] The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin [J].

Besarab, A ;

Bolton, WK ;

Browne, JK ;

Egrie, JC ;

Nissenson, AR ;

Okamoto, DM ;

Schwab, SJ ;

Goodkin, DA .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) :584-590

[4] What crit? [J].

Bolton, WK .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 33 (06) :1177-1179

[5] Higher haematocrit levels: do they improve patient outcomes, and are they cost effective? [J].

Collins, AJ ;

Keane, WF .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (07) :1627-1629

[6]

Danielson Bo G., 1999, Journal of the American Society of Nephrology, V10, p160A

[7]

*EUR BEST PRACT GU, 1999, NEPHROL DIAL TRAN S5, V14, P11

[8] Increased risk of cardiovascular disease with erythropoietin in chronic dialysis patients [J].

Iseki, K ;

Nishime, K ;

Uehara, H ;

Tokuyama, K ;

Toma, S ;

Yoshihara, K ;

Kowatari, T ;

Terukina, S ;

Osawa, A ;

Fukiyama, K .

NEPHRON, 1996, 72 (01) :30-36

[9] Normalization of haemoglobin: why not? [J].

Jacobs, C .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 :75-79

[10] The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity - the experience of the Lombardy Dialysis Registry [J].

Locatelli, F ;

Conte, F ;

Marcelli, D .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (07) :1642-1644

← 1 2 3 →